NDC 58657-454

Me NaPhos MB Hyo 1

Urinary Antiseptic Antispasmodic

Me NaPhos MB Hyo 1 is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Method Pharmaceuticals. The primary component is Methenamine; Sodium Phosphate, Monobasic, Monohydrate; Methylene Blue Anhydrous; Hyoscyamine Sulfate Anhydrous.

Product ID58657-454_7eb8ae5e-495d-2cb9-e053-2a91aa0a74cb
NDC58657-454
Product TypeHuman Prescription Drug
Proprietary NameMe NaPhos MB Hyo 1
Generic NameUrinary Antiseptic Antispasmodic
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameMethod Pharmaceuticals
Substance NameMETHENAMINE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; METHYLENE BLUE ANHYDROUS; HYOSCYAMINE SULFATE ANHYDROUS
Active Ingredient Strength82 mg/1; mg/1; mg/1; mg/1
Pharm ClassesOxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 58657-454-01

100 TABLET in 1 BOTTLE (58657-454-01)
Marketing Start Date2015-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58657-454-01 [58657045401]

Me NaPhos MB Hyo 1 TABLET
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-12-01

Drug Details

Active Ingredients

IngredientStrength
METHENAMINE81.6 mg/1

OpenFDA Data

SPL SET ID:2ae628e7-3b33-6a9a-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1050325
  • UPC Code
  • 0358657454012
  • Pharmacological Class

    • Oxidation-Reduction Activity [MoA]
    • Oxidation-Reduction Agent [EPC]
    • Oxidation-Reduction Activity [MoA]
    • Oxidation-Reduction Agent [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.